1. Home
  2. FSBW vs ESPR Comparison

FSBW vs ESPR Comparison

Compare FSBW & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$39.38

Market Cap

312.1M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.66

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
ESPR
Founded
1936
2008
Country
United States
United States
Employees
537
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
731.9M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
FSBW
ESPR
Price
$39.38
$2.66
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$46.00
$7.60
AVG Volume (30 Days)
8.5K
5.2M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
3.01%
N/A
EPS Growth
N/A
60.71
EPS
4.29
N/A
Revenue
$4,612,000.00
$403,135,000.00
Revenue This Year
$14.94
$2.92
Revenue Next Year
$10.47
N/A
P/E Ratio
$9.00
N/A
Revenue Growth
44.80
21.31
52 Week Low
$34.61
$0.73
52 Week High
$44.22
$4.18

Technical Indicators

Market Signals
Indicator
FSBW
ESPR
Relative Strength Index (RSI) 51.45 41.86
Support Level $39.44 $2.37
Resistance Level $40.67 $3.02
Average True Range (ATR) 1.25 0.18
MACD 0.17 0.03
Stochastic Oscillator 85.35 37.62

Price Performance

Historical Comparison
FSBW
ESPR

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: